What is Forty Seven Earnings Power Value (EPV)?
As of Dec19, Forty Seven's earnings power value is $7.54. *
* GuruFocus does not store EPV value into our database if Average Maintenance CAPEX is 0.
Margin of Safety is
N/A.
The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future. Assumption: Current profitability is sustainable.
Forty Seven Earnings Power Value (EPV) Historical Data
The historical data trend for Forty Seven's Earnings Power Value (EPV) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forty Seven Earnings Power Value (EPV) Chart
|
Forty Seven Annual Data
|
|
Trend |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
| Earnings Power Value (EPV) |
|
- |
- |
- |
- |
|
Forty Seven Quarterly Data
|
|
Dec16 |
Mar17 |
Jun17 |
Sep17 |
Dec17 |
Mar18 |
Jun18 |
Sep18 |
Dec18 |
Mar19 |
Jun19 |
Sep19 |
Dec19 |
| Earnings Power Value (EPV) |
Get a 7-Day Free Trial
|
|
|
|
|
|
- |
- |
- |
- |
- |
Competitive Comparison of Forty Seven's Earnings Power Value (EPV)
For the Biotechnology subindustry, Forty Seven's Earnings Power Value (EPV), along with its competitors' market caps and Earnings Power Value (EPV) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Forty Seven's Earnings Power Value (EPV) Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Forty Seven's Earnings Power Value (EPV) distribution charts can be found below:
* The bar in red indicates where Forty Seven's Earnings Power Value (EPV) falls into.
Forty Seven Earnings Power Value (EPV) Calculation
Earnings Power Value also known as just Earnings Power is a valuation technique popularised by Bruce Greenwald, an authority on value investing at Columbia University. It is arguably a better way to analyze stocks than Discounted Cash Flow analysis that relies on highly speculative growth assumptions many years into the future.
The basic concept of EPV is that one should value a stock based on the current free cash flow of a company and not on future projections which may, or may not, come true. This valuation tool excludes the potential growth that a company may have so that needs to be looked at separately. Since future growth is excluded from the analysis, only the maintenance capital expenditures are subtracted from after-tax EBIT (earnings before interest and taxes) and growth capex is ignored.
Forty Seven (Forty Seven) Business Description
Traded in Other Exchanges
N/A
Address
1490 O’Brien Drive, Suite A, Menlo Park, CA, USA, 94025
Forty Seven Inc is a clinical-stage immuno-oncology company. It is engaged in developing novel checkpoint therapies to activate macrophages and help the patients in their fight against cancer. It founded that blocking CD47, a key signaling molecule that is overexpressed on cancer cells renders tumors susceptible to macrophages. It is also preparing investigational compounds into clinical testing. FSI-174, an anti-cKIT antibody, is being developed in combination with magrolimab as a novel, all-antibody conditioning regimen to address the limitations of current stem cell transplantation conditioning regimens. FSI-189, an anti-SIRP-alpha antibody, is being developed for the treatment of cancer, and certain non-oncology conditions, including transplantation conditioning.
Executives
| Dennis Henner |
director |
THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH FLOOR, BOSTON MA 02116 |
| Kristine M Ball |
director |
C/O RELYPSA, INC., 700 SAGINAW DRIVE, REDWOOD CITY CA 94063 |
| Ann D Rhoads |
officer: Chief Financial Officer |
4000 NORTH FIRST STREET, SAN JOSE CA 95134 |
| Ian T Clark |
director |
SOLAZYME, INC., 225 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080 |
| Jeffrey W Bird |
director |
755 PAGE MILL RD STE A-200, PALO ALTO CA 94304-1005 |
| Lightspeed General Partner X, L.p. |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Lightspeed Ultimate General Partner X, Ltd. |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Jeremy Liew |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Lightspeed Venture Partners X, L.p. |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Barry Eggers |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Peter Nieh |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Ravi Mhatre |
10 percent owner |
2200 SAND HILL ROAD, MENLO PARK CA 94025 |
| Stephen A Schwarzman |
10 percent owner |
C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154 |
| Blackstone Clarus Iii L.l.c. |
10 percent owner |
C/O THE BLACKSTONE GROUP L.P., 345 PARK AVENUE, NEW YORK NY 10154 |
| Blackstone Inc. |
10 percent owner |
345 PARK AVENUE, NEW YORK NY 10154 |
Forty Seven (Forty Seven) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FTSV has been successfully added to your